These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemia. Shao Y; Li X; Shi J; Ge M; Huang J; Huang Z; Zhang J; Nie N; Zheng Y Br J Haematol; 2013 Aug; 162(4):552-5. PubMed ID: 23700976 [No Abstract] [Full Text] [Related]
5. C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. Baraldo M; Francesconi A; Barbone F; Tursi V; Livi U; Furlanut M Transplant Proc; 2002 Dec; 34(8):3246-8. PubMed ID: 12493435 [No Abstract] [Full Text] [Related]
6. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study. Jalaeikhoo H; Khajeh-Mehrizi A PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182 [TBL] [Abstract][Full Text] [Related]
7. Cyclosporine peak concentration in relation to the four-hour absorption phase in pediatric renal graft recipients. Wigger M; Drückler E; Muscheites J; Stolpe HJ; Kundt G; Wacke R Transplant Proc; 2001; 33(7-8):3126-7. PubMed ID: 11750344 [No Abstract] [Full Text] [Related]
8. Fatal acute hepatic failure induced by danazol in a patient with endometriosis and aplastic anemia. Hayashi T; Takahashi T; Minami T; Akaike J; Kasahara K; Adachi M; Hinoda Y; Takahashi S; Hirayama T; Imai K J Gastroenterol; 2001 Nov; 36(11):783-6. PubMed ID: 11757752 [TBL] [Abstract][Full Text] [Related]
9. Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia. Wang M; Li X; Shi J; Shao Y; Ge M; Huang J; Huang Z; Zhang J; Nie N; Zheng Y Int J Hematol; 2015 Aug; 102(2):149-56. PubMed ID: 26072293 [TBL] [Abstract][Full Text] [Related]
10. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral). Foradori A; Pinto VM; Elberg A Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235 [No Abstract] [Full Text] [Related]
11. [Cyclosporin A in aplastic anemia in dogs: first results]. Barth T; Mischke R; Nolte I Berl Munch Tierarztl Wochenschr; 1997 Feb; 110(2):60-7. PubMed ID: 9139630 [TBL] [Abstract][Full Text] [Related]
12. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin. Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up. Saracco P; Quarello P; Iori AP; Zecca M; Longoni D; Svahn J; Varotto S; Del Vecchio GC; Dufour C; Ramenghi U; Bacigalupo A; Locasciulli A; Br J Haematol; 2008 Jan; 140(2):197-205. PubMed ID: 18173756 [TBL] [Abstract][Full Text] [Related]
14. Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants. Foradori A; Mezzano S; Videla C; Pefaur J; Elberg A Transplant Proc; 1998 Aug; 30(5):1685-7. PubMed ID: 9723244 [No Abstract] [Full Text] [Related]
18. Area under the concentration curve values in pediatric liver transplant recipients on cyclosporin microemulsion formulation. Dunn SP; Kulinsky A; Falkenstein K; Pierson A; Chang CT; Cooney GF Transplant Proc; 1998 Aug; 30(5):1678-9. PubMed ID: 9723240 [No Abstract] [Full Text] [Related]
19. The impact of cyclosporin formulation on clinical outcomes. Holt DW; Johnston A Transplant Proc; 2000 Nov; 32(7):1552-5. PubMed ID: 11119831 [No Abstract] [Full Text] [Related]
20. [Cyclosporin A and erhuang sangshenzi decoction in treating 32 cases of severe aplastic anemia]. Yu R; Luo X; Zhu X Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Nov; 19(11):668-9. PubMed ID: 11783159 [No Abstract] [Full Text] [Related] [Next] [New Search]